Validation of an Allergic Rhinitis Control Test in Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-04

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Validation of an Allergic Rhinitis Control Test in Teenagers

NCT02818153

Allergic Rhinitis

UNKNOWN NA

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

NCT04544774

Perennial Allergic Rhinitis Seasonal Allergic Rhinitis Local Allergic Rhinitis

RECRUITING

Perennial Allergic Rhinitis In Pediatric Subjects

NCT00257595

Rhinitis, Allergic, Perennial

COMPLETED PHASE3

Observational Study of Allergic Rhinitis in Children

NCT05655858

Allergic Rhinitis

COMPLETED

Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy In Southern Europe.

NCT03636919

Allergic Rhinitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergic Rhinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

questionnaire for allergic rhinitis control children from 5 to 11 years old who complete a self questionnaire regarding allergic rhinitis control during the consultation and after 15 days

Group Type EXPERIMENTAL

Self Questionnaire

Intervention Type OTHER

self questionnaire for allergic rhinitis control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Self Questionnaire

self questionnaire for allergic rhinitis control

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
* Parents formulated their study participation agreement by signing the consent form.